144.44 0.00 (0.00%)
After hours: 4:28PM EDT
|Bid||144.75 x 900|
|Ask||144.76 x 900|
|Day's Range||143.36 - 147.79|
|52 Week Range||99.14 - 156.66|
|Beta (3Y Monthly)||0.75|
|PE Ratio (TTM)||38.72|
|Earnings Date||Nov 4, 2019 - Nov 8, 2019|
|Forward Dividend & Yield||1.48 (1.02%)|
|1y Target Est||168.50|
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see STERIS plc...
Dublin, Ireland, Aug. 26, 2019 -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Global Healthcare Conference on.
Today we'll look at STERIS plc (NYSE:STE) and reflect on its potential as an investment. In particular, we'll consider...
President & CEO of Steris Plc (30-Year Financial, Insider Trades) Walter M Rosebrough Jr (insider trades) sold 102,500 shares of STE on 08/08/2019 at an average price of $151.78 a share. Continue reading...
Steris (STE) delivered earnings and revenue surprises of 10.81% and 3.46%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
STERIS plc (STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2020 first quarter ended June 30, 2019. Revenue as reported for the quarter increased 9% to $696.8 million compared with $638.8 million in the first quarter of fiscal 2019, with growth across all segments. Constant currency organic revenue (see Non-GAAP Financial Measures) growth was 10% for the first quarter of fiscal 2020.
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
For those unable to listen to the conference call live, a replay will be available beginning at 12:00 p.m. Eastern Time on August 6, 2019, either over the Internet at www.steris-ir.com or via phone. To access the replay of the call, please use the access code 10133575 and dial 1-877-344-7529 in the United States or 1-412-317-0088 internationally. STERIS’s mission is to HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe.
Insulet (PODD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Every investor in STERIS plc (NYSE:STE) should be aware of the most powerful shareholder groups. Generally speaking...
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]
Steris plc NYSE:STEView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for STE with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $1.13 billion over the last one-month into ETFs that hold STE are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
President & CEO of Steris Ltd (NYSE:STE) Walter M Rosebrough Jr sold 119,000 shares of STE on 05/31/2019 at an average price of $132.56 a share.